Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is Michelle and I will facilitate today ...

Mpox and Smallpox Vaccine Platform GEO-MVA is GeoVax’s vaccine candidate in development for protection against Mpox and Smallpox. A cGMP Master Seed Virus has been successfully manufactured and ...

The company is advancing its vaccine candidate against monkeypox and smallpox, with production of the first CGMP clinical ...

Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

Vaccines have helped eradicate or reduce the prevalence of diseases that once caused widespread suffering and death, ...

Vaccination drive all over the world in the last half century has contributed vastly in eradicating many vaccine preventable ...

Emergent BioSolutions says its smallpox treatment to be evaluated in mpox trial in Africa. On Thursday, Emergent BioSolutions ...

Nineteen African states—those currently reporting or that have reported Mpox cases within this outbreak—gathered in a ‘back-to-school’ style meeting in Congo Brazzaville in the first week of November.

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Ladapo and RFK Jr. would make a great tag-team ushering back in a world of diphtheria, small pox, grippe, horrors and night ...